Stay updated on Roxadustat Long-Term Efficacy & Safety in CKD Clinical Trial
Sign up to get notified when there's something new on the Roxadustat Long-Term Efficacy & Safety in CKD Clinical Trial page.

Latest updates to the Roxadustat Long-Term Efficacy & Safety in CKD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry, v3.4.2, was added to the history, and the prior notices about government funding lapse and operating status (v3.4.1) were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the record revision from v3.4.0 to v3.4.1. These changes are administrative and do not affect the trial data or study details.SummaryDifference0.9%

- Check28 days agoChange DetectedThe history page adds a glossary display, color-coded green/red highlights for additions/deletions, and a new revision note (v3.4.0), while the prior 'No FEAR Act' entry is removed.SummaryDifference1%

- Check35 days agoChange DetectedSponsor/Responsible Party changed from FibroGen to Kyntra Bio, and the record revision updated to v3.3.4 (from v3.3.3).SummaryDifference0.3%

- Check65 days agoChange DetectedRevision: v3.3.3 was added, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer.SummaryDifference0.2%

- Check86 days agoChange DetectedThe Record History now includes a new revision entry (v3.3.2).SummaryDifference0.1%

Stay in the know with updates to Roxadustat Long-Term Efficacy & Safety in CKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat Long-Term Efficacy & Safety in CKD Clinical Trial page.